Liesbet Lagae

Liesbet Lagae


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2016 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
EMEvelien Mathieu
Evelien Mathieu
CPColin D. Paul
Colin D. Paul
RSRichard Stahl
Richard Stahl
GVGeert Vanmeerbeeck
Geert Vanmeerbeeck
VRVeerle Reumers
Veerle Reumers
LLLiesbet Lagae
Liesbet Lagae
Lens-free imaging using coherent illumination is established as an inexpensive and reliable alternative to conventional phase contrast microscopy for live-cell imaging applications.

23 October 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
ADAntoine D’hollander
Antoine D’hollander
Greetje Vande VeldeGreetje Vande Velde
Greetje Vande Velde
HJHilde Jans
Hilde Jans
BVBram Vanspauwen
Bram Vanspauwen
EVElien Vermeersch
Elien Vermeersch
UHUwe Himmelreich
Uwe Himmelreich
Gold nanoparticles offer the possibility to combine both imaging and therapy of otherwise difficult to treat tumors. To validate and further improve their potential, we describe the use of gold nanostars that were functionalized with a polyethyleneglycol-maleimide coating for in vitro and in vivo photoacoustic imaging (PAI), computed tomography (CT), as well as photothermal therapy (PTT) of cancer cells and tumor masses, respectively. Nanostar shaped particles show a high absorption coefficient in the near infrared region and have a hydrodynamic size in biological medium around 100 nm, which allows optimal intra-tumoral retention. Using these nanostars for in vitro labeling of tumor cells, high intracellular nanostar concentrations could be achieved, resulting in high PAI and CT contrast and effective PTT. By injecting the nanostars intratumorally, high contrast could be generated in vivo using PAI and CT, which allowed successful multi-modal tumor imaging. PTT was successfully induced, resulting in tumor cell death and subsequent inhibition of tumor growth. Therefore, gold nanostars are versatile theranostic agents for tumor therapy.

17 October 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
BDBastien Duckert
Bastien Duckert
MFMaarten Fauvart
Maarten Fauvart
PGPeter Goos
Peter Goos
TSTim Stakenborg
Tim Stakenborg
LLLiesbet Lagae
Liesbet Lagae
DBDries Braeken
Dries Braeken

25 August 2023 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
BDBastien Duckert
Bastien Duckert
DLDennis Lambrechts
Dennis Lambrechts
DBDries Braeken
Dries Braeken
LLLiesbet Lagae
Liesbet Lagae
MFMaarten Fauvart
Maarten Fauvart

20 December 2023 in Cells
Verified
Journal Article
Open access
PDF file
SLSarah Libbrecht
Sarah Libbrecht
Ann VankerckhovenAnn Vankerckhoven
Ann Vankerckhoven
KWKoen de Wijs
Koen de Wijs
TBThaïs Baert
Thaïs Baert
GTGitte Thirion
Gitte Thirion
LLLiesbet Lagae
Liesbet Lagae
Among cancer diagnoses in women, ovarian cancer has the fifth-highest mortality rate. Current treatments are unsatisfactory, and new therapies are highly needed. Immunotherapies show great promise but have not reached their full potential in ovarian cancer patients. Implementation of an immune readout could offer better guidance and development of immunotherapies. However, immune profiling is often performed using a flow cytometer, which is bulky, complex, and expensive. This equipment is centralized and operated by highly trained personnel, making it cumbersome and time-consuming. We aim to develop a disposable microfluidic chip capable of performing an immune readout with the sensitivity needed to guide diagnostic decision making as close as possible to the patient. As a proof of concept of the fluidics module of this concept, acquisition of a limited immune panel based on CD45, CD8, programmed cell death protein 1 (PD1), and a live/dead marker was compared to a conventional flow cytometer (BD FACSymphony). Based on a dataset of peripheral blood mononuclear cells of 15 patients with ovarian cancer across different stages of treatment, we obtained a 99% correlation coefficient for the detection of CD8+PD1+ T cells relative to the total amount of CD45+ white blood cells. Upon further system development comprising further miniaturization of optics, this microfluidics chip could enable immune monitoring in an outpatient setting, facilitating rapid acquisition of data without the need for highly trained staff.

14 January 2019 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
YVYannick Vervoort
Yannick Vervoort
RWRodrigo Sergio Wiederkehr
Rodrigo Sergio Wiederkehr
MSMichiel Smets
Michiel Smets
MFMaarten Fauvart
Maarten Fauvart
TSTim Stakenborg
Tim Stakenborg
KVKevin Verstrepen
Kevin Verstrepen

Abstract

Sulfite is often added to beverages as an antioxidant and antimicrobial agent. In fermented beverages, sulfite is also naturally produced by yeast cells. However, sulfite causes adverse health effects in asthmatic patients and accurate measurement of the sulfite concentration is therefore very important. Current sulfite analysis methods are time- and reagent-consuming and often require costly equipment. Here, we present a system allowing sensitive, ultralow-volume sulfite measurements based on a reusable glass-silicon microdroplet platform on which microdroplet generation, addition of enzymes through chemical-induced emulsion destabilization and pillar-induced droplet merging, emulsion restabilization, droplet incubation, and fluorescence measurements are integrated. In a first step, we developed and verified a fluorescence-based enzymatic assay for sulfite by measuring its analytical performance (LOD, LOQ, the dynamic working range, and the influence of salts, colorant, and sugars) and comparing fluorescent microplate readouts of fermentation samples with standard colorimetric measurements using the 5,5′-dithiobis-(2-nitrobenzoic acid) assay of the standard Gallery Plus Beermaster analysis platform. Next, samples were analyzed on the microdroplet platform, which also showed good correlation with the standard colorimetric analysis. Although the presented platform does not allow stable reinjection of droplets due to the presence of a tight array of micropillars at the fluidics entrances to prevent channel clogging by dust, removing the pillars, and integrating miniaturized pumps and optics in a future design would allow to use this platform for high-throughput, automated, and portable screening of microbes, plant, or mammalian cells.

ᅟ